TRVI icon

Trevi Therapeutics
TRVI

Overview Fund Trends Analyst Outlook Journalist View
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$22
132% upside
High target

3 analyst ratings

3  positive
100%
0  neutral
0%
0  negative
0%
Analyst & Firm Rating Price Target Upside
Downside 		Date
Morgan Stanley
Morgan Stanley
Judah Frommer
100% 1-yr win rate
21 Aug ‘25 1 month ago
Raymond James
Raymond James
Ryan Deschner
100% 1-yr win rate
8 Aug ‘25 2 months ago
Needham
Needham
Serge Belanger
63% 1-yr win rate
8 Aug ‘25 2 months ago